Dyslipidemias: all 1,101 studies
Page 9 of 12. Open to participants first (161), then studies with results posted, then the rest; newest registration first within each.
- Stress and Sugar SynergyCompletedNCT02143011Not applicable
- Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)CompletedNCT02126358Phase 3
- The HDL Particle Protection StudyCompletedNCT02125682Phase 4
- The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant PatientsCompletedNCT02103049Phase 4
- Soda and Milk StudyCompletedNCT02094768Not applicable
- A Thorough Corrected QT Interval TrialCompletedNCT02073084Phase 1
- Dyslipidemia-related Risk Factors in DialysisCompletedNCT02072837
- CKD-337 Drug Interaction StudyCompletedNCT02066207Phase 1
- A Study on Postmarketing Xuezhikang Capsule for Treating DyslipidemiaCompletedNCT02057302Phase 4
- An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid LevelsStatus unknownNCT02052986Phase 2
- Efficacy of a New Symbiotic Formulation in Children With Familial HypercholesterolemiaCompletedNCT02048410Phase 1/2
- Improving Adherence to Statins Among Minority PopulationsCompletedNCT02037685Not applicable
- Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic RiskActive, not recruitingNCT02037321
- Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)Status unknownNCT02035644Phase 4
- Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and EzetimibeCompletedNCT02029625Phase 1
- Alternative Treatments for Menopausal WomenCompletedNCT02028702Not applicable
- Treatment of Overweight and Obese Children -Using the "Holbaek-Method" in a Municipality Based Treatment Program.CompletedNCT02013843Not applicable
- Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic AbnormalitiesCompletedNCT01990391Not applicable
- Characterization of Dyslipidemia in Adolescent ObesityCompletedNCT01988454
- Effects of Niacin On Fatty Acid TrappingCompletedNCT01984073Phase 1
- PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and RosuvastatinCompletedNCT01975961Phase 1
- Efficacy and Safety of PRC-4016 in Subjects With Mixed DyslipidemiaTerminatedNCT01972178Phase 2
- Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)Status unknownNCT01972113Not applicable
- TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)CompletedNCT01970215Phase 2
- Is a Smartphone Application Effective as an Oral Medication Adherence AidTerminatedNCT01968876Early Phase 1
- Pilot Study To Assess CAT-2003 in Patients With Severe HypertriglyceridemiaCompletedNCT01968720Phase 2
- Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid ApheresisCompletedNCT01967355Not applicable
- Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2CompletedNCT01958775Phase 3
- Pilot Study To Assess CAT-2003 in Patients With HyperlipidemiaCompletedNCT01912560Phase 2
- Dyslipidemia Management in Chinese Post Stroke PatientsCompletedNCT01897883
- The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic SubjectsCompletedNCT01893515Phase 2
- Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment StudyCompletedNCT01884714Not applicable
- Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk FactorsCompletedNCT01883401Not applicable
- Lipid-lowering Effect of Plant Stanol YogurtCompletedNCT01882517Not applicable
- Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy SubjectsCompletedNCT01879020Phase 1
- Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy SubjectsCompletedNCT01878474Phase 1
- Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in DyslipidemiaTerminatedNCT01863225Phase 2
- Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic SyndromeCompletedNCT01806142Not applicable
- Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) MetabolismCompletedNCT01803594Not applicable
- Effects of Almond Intake on Atherogenic Lipoprotein ParticlesCompletedNCT01792648Not applicable
- Metformin for Treatment of Antipsychotic-induced DyslipidemiaCompletedNCT01778244Phase 4
- Intima Media Thickness Regression in Dyslipidemic TeenagersCompletedNCT01768481Phase 3
- Clinical Study for Patients With Hypertension Associated With DyslipidemiaCompletedNCT01764295Phase 3
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)CompletedNCT01760460Phase 3
- Dyslipidemia International Survey-ChinaStatus unknownNCT01732952
- A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003CompletedNCT01725594Phase 1
- Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT01720719Phase 4
- Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based RegimenStatus unknownNCT01705873
- The Therapeutic Effects of Statins and Berberine on the HyperlipemiaTerminatedNCT01697735Phase 4
- The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older AdultsCompletedNCT01696097Not applicable
- Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With DyslipidemiaCompletedNCT01695837Not applicable
- HIV Reverse Cholesterol Transport StudyStatus unknownNCT01670968
- Diet Intervention and GEnetic STudy (DIGEST-Pilot)Status unknownNCT01658137Not applicable
- Micro-Clinic Obesity and Metabolic Risk Prevention ProgramCompletedNCT01651065Not applicable
- Safety and Pharmacokinetis of TAP311 in Dyslipidemic PatientsCompletedNCT01632358Phase 1
- Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic SyndromeCompletedNCT01630980
- Efficacy and Safety Study of 5 mg and 10 mg RosuvastatinStatus unknownNCT01613729Phase 4
- Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk IndicatorsCompletedNCT01610661Not applicable
- Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic DiseaseStatus unknownNCT01608620
- Supplementation With Flaxseed Oil in the State of Rio de JaneiroStatus unknownNCT01604681Not applicable
- Physiological Study of Human Cholesterol Metabolism and ExcretionCompletedNCT01603758Phase 1
- Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic PatientsCompletedNCT01600690Phase 4
- Meta-analyses of Dietary Pulses and Cardiometabolic RiskStatus unknownNCT01594567
- A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)WithdrawnNCT01587235Phase 4
- A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol TargetsCompletedNCT01581372Not applicable
- Genetic Influences on Statin Blood Concentrations in African AmericansCompletedNCT01569867
- Genetic Influence on Statin PharmacodynamicsWithdrawnNCT01569854
- The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride MetabolismCompletedNCT01564550
- Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen)Status unknownNCT01563770Not applicable
- Beetroot Juice and Postprandial Vascular ActivityCompletedNCT01559441Not applicable
- A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With DyslipidemiaCompletedNCT01539616Phase 2
- Effect of Nigella Sativa on Lipid Profiles in ElderlyCompletedNCT01531062Phase 2
- A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular DiseaseCompletedNCT01516541Phase 3
- Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting StentsCompletedNCT01502904Phase 4
- Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 DiabetesCompletedNCT01497912Phase 4
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic PatientsCompletedNCT01487460Phase 1
- Lipid Metabolic Status in Thyroid CarcinomaCompletedNCT01487057
- Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRPStatus unknownNCT01486667Phase 3
- Reduced Cardiac Rehabilitation ProgramCompletedNCT01483235Not applicable
- Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505CompletedNCT01474161Phase 1
- Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease InhibitorsCompletedNCT01458977Phase 4
- Regulation of Intestinal and Hepatic Lipoprotein Secretion by ResveratrolCompletedNCT01451918Phase 2
- Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDLTerminatedNCT01450410Phase 4
- Longitudinal Study of Multi-Analyte Profile for DyslipidemiaStatus unknownNCT01441908Not applicable
- Reducing Disparities in Late Life Depression and Metabolic SyndromeCompletedNCT01428791Not applicable
- Dietary Protein Sources and Atherogenic DyslipidemiaCompletedNCT01427855Not applicable
- The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I StimulationCompletedNCT01423188Phase 2
- Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery DiseaseCompletedNCT01422421Phase 4
- TRANSforming InTerprofessional Cardiovascular Prevention in Primary CareCompletedNCT01418716Not applicable
- The Health Effect of Diet Rich in Nordic BerriesCompletedNCT01414647Not applicable
- Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy IndividualsCompletedNCT01404897Not applicable
- Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and DyslipidemiaCompletedNCT01402843Phase 3
- Reduction of Sweetened Beverages and Intrahepatic FatCompletedNCT01394380Not applicable
- Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in KoreaCompletedNCT01372956
- Resveratrol and Serum Apo A-ICompletedNCT01364961Not applicable
- Meta-analyses of Fructose and Cardiometabolic RiskStatus unknownNCT01363791
- The Effects of Orange Juice on Plasma LipidsCompletedNCT01350843Not applicable
- Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular DiseaseTerminatedNCT01308203Phase 4
- Management of Dyslipidemia in Adult Type 2 Diabetes Patients in IndiaCompletedNCT01292018
- The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With HypercholesterolemiaCompletedNCT01285544Phase 4